highly significantp < 0.01
As shown for PC3 cells by Caspase 3/7 assays ( Figure 1(e) ), TRAIL administration compared to control strengthened relative apoptosis in a highly significant manner (188.6 ± 34.4%, p < 0.01).
As shown for PC3 cells by Caspase 3/7 assays ( Figure 1(e) ), TRAIL administration compared to control strengthened relative apoptosis in a highly significant manner (188.6 ± 34.4%, p < 0.01).
Whereas miR-221 overexpressing LNCaP cells showed a trend towards higher cell viability ( p = 0.054), the comparison between TRAIL-treated LNCaP cells after pre-miR-221 or control transfections was statistically significant (119.5 ± 19.7% vs. 84.8 ± 5.6%, p = 0.013).